Association between Polypharmacy and Depression, Anxiety and Stress in Elderly: A Cross-Sectional Study

Objective: This study aimed to examine the association between polypharmacy and depression, anxiety and stress in elderly. Methods: This cross-sectional study was conducted with 396 elderly admitted to two different hospitals in a province in eastern Türkiye. Information Form and Depression Anxiety...

Full description

Saved in:
Bibliographic Details
Main Authors: Ayşenur Sarıaslan, Berna Aktaş
Format: Article
Language:English
Published: Atatürk University 2025-06-01
Series:Journal of Nursology
Subjects:
Online Access:https://dergipark.org.tr/tr/download/article-file/4373688
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849329169664573440
author Ayşenur Sarıaslan
Berna Aktaş
author_facet Ayşenur Sarıaslan
Berna Aktaş
author_sort Ayşenur Sarıaslan
collection DOAJ
description Objective: This study aimed to examine the association between polypharmacy and depression, anxiety and stress in elderly. Methods: This cross-sectional study was conducted with 396 elderly admitted to two different hospitals in a province in eastern Türkiye. Information Form and Depression Anxiety Stress Scale-21 were used to collect data. The data were obtained between August and September 2023.Results: Polypharmacy was present in 43.7% of the elderly. In the study, it was determined that income status (OR=0.385; %95 GA=0.163-0.909, P=.029), hypertension (OR=3.899; 95% CI=1.606-9.466, P=.003), coronary artery disease (OR=6.677; 95% CI=2.620-17.020, P=.001), diabetes (OR=3.924; 95% CI=1.543-9.981, P=.004), lung disease (OR=8.893; 95% CI=2.909-27.180, P<.001), hyperlipidemia (OR=20.023; 95% CI=5.737-69.887, P<.001), kidney disease (OR=16.514; 95% CI=5.873-46.431, P<.001), thyroid disease (OR=7.213; 95% CI=2.255-23.079, P<.001), cancer (OR=24.783; 95% CI=6.755-90.933, P<.001) and thinking that they were using too much drug (OR=0.484; 95% CI=0.233-1.005, P=.052) were significant risk factors for polypharmacy. It was observed that the presence of depression, anxiety and stress was not a significant risk factor for polypharmacy in the elderly (P>.05). Conclusion: Further study on association between polypharmacy and depression, anxiety and stress in elderly is necessary. In future studies, it is recommended to use more comprehensive measurement tools, to evaluate which group the medicines used by the elderly belong to and to test causality.
format Article
id doaj-art-978512edf2c942768e7b6a23ec730451
institution Kabale University
issn 2822-2954
language English
publishDate 2025-06-01
publisher Atatürk University
record_format Article
series Journal of Nursology
spelling doaj-art-978512edf2c942768e7b6a23ec7304512025-08-20T03:47:20ZengAtatürk UniversityJournal of Nursology2822-29542025-06-0128219720510.17049/jnursology.158692755Association between Polypharmacy and Depression, Anxiety and Stress in Elderly: A Cross-Sectional StudyAyşenur Sarıaslan0https://orcid.org/0000-0001-8005-1067Berna Aktaş1https://orcid.org/0000-0002-8722-8299KAFKAS ÜNİVERSİTESİ, SAĞLIK BİLİMLERİ FAKÜLTESİKAFKAS ÜNİVERSİTESİ, SAĞLIK BİLİMLERİ FAKÜLTESİObjective: This study aimed to examine the association between polypharmacy and depression, anxiety and stress in elderly. Methods: This cross-sectional study was conducted with 396 elderly admitted to two different hospitals in a province in eastern Türkiye. Information Form and Depression Anxiety Stress Scale-21 were used to collect data. The data were obtained between August and September 2023.Results: Polypharmacy was present in 43.7% of the elderly. In the study, it was determined that income status (OR=0.385; %95 GA=0.163-0.909, P=.029), hypertension (OR=3.899; 95% CI=1.606-9.466, P=.003), coronary artery disease (OR=6.677; 95% CI=2.620-17.020, P=.001), diabetes (OR=3.924; 95% CI=1.543-9.981, P=.004), lung disease (OR=8.893; 95% CI=2.909-27.180, P<.001), hyperlipidemia (OR=20.023; 95% CI=5.737-69.887, P<.001), kidney disease (OR=16.514; 95% CI=5.873-46.431, P<.001), thyroid disease (OR=7.213; 95% CI=2.255-23.079, P<.001), cancer (OR=24.783; 95% CI=6.755-90.933, P<.001) and thinking that they were using too much drug (OR=0.484; 95% CI=0.233-1.005, P=.052) were significant risk factors for polypharmacy. It was observed that the presence of depression, anxiety and stress was not a significant risk factor for polypharmacy in the elderly (P>.05). Conclusion: Further study on association between polypharmacy and depression, anxiety and stress in elderly is necessary. In future studies, it is recommended to use more comprehensive measurement tools, to evaluate which group the medicines used by the elderly belong to and to test causality.https://dergipark.org.tr/tr/download/article-file/4373688polifarmasidepresyonanksiyetestresyaşlıpolypharmacydepressionanxietystresselderly
spellingShingle Ayşenur Sarıaslan
Berna Aktaş
Association between Polypharmacy and Depression, Anxiety and Stress in Elderly: A Cross-Sectional Study
Journal of Nursology
polifarmasi
depresyon
anksiyete
stres
yaşlı
polypharmacy
depression
anxiety
stress
elderly
title Association between Polypharmacy and Depression, Anxiety and Stress in Elderly: A Cross-Sectional Study
title_full Association between Polypharmacy and Depression, Anxiety and Stress in Elderly: A Cross-Sectional Study
title_fullStr Association between Polypharmacy and Depression, Anxiety and Stress in Elderly: A Cross-Sectional Study
title_full_unstemmed Association between Polypharmacy and Depression, Anxiety and Stress in Elderly: A Cross-Sectional Study
title_short Association between Polypharmacy and Depression, Anxiety and Stress in Elderly: A Cross-Sectional Study
title_sort association between polypharmacy and depression anxiety and stress in elderly a cross sectional study
topic polifarmasi
depresyon
anksiyete
stres
yaşlı
polypharmacy
depression
anxiety
stress
elderly
url https://dergipark.org.tr/tr/download/article-file/4373688
work_keys_str_mv AT aysenursarıaslan associationbetweenpolypharmacyanddepressionanxietyandstressinelderlyacrosssectionalstudy
AT bernaaktas associationbetweenpolypharmacyanddepressionanxietyandstressinelderlyacrosssectionalstudy